Market Samachar
STAT
·
GLOBAL
·
Lilly shares safety, tolerability data on its next-gen obesity drug - statnews.com
As reported by STAT
Eli Lilly presented new safety and tolerability data on retatrutide at the annual meeting of the American Diabetes Association on Saturday.
▸ MARKET SAMACHAR VIEW
NEUTRAL
Read full article on STAT ↗
Market Samachar is a news aggregator. This article was originally published by
STAT. Tap the button above to read the full story on their site.
🔥 Hot Now
Top stories across markets in the last hour
More from Market Samachar